Paper22010101
No difference in outcome between children and adolescents transplanted for acute lymphoblastic leukemia in second remission.
Dini G and 15 others. Blood, 2011. Cited by 40 papers, by iCite.
Cite this record
ConductScience Library. No difference in outcome between children and adolescents transplanted for acute lymphoblastic leukemia in second remission. Papers, record 22010101. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22010101
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- No difference in outcome between children and adolescents transplanted for acute lymphoblastic leukemia in second remission.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hematopoietic Stem Cell Transplantation | Major topic |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | Major topic |
| Adolescent | |
| Chemoradiotherapy | |
| Child | |
| Child, Preschool | |
| Cohort Studies | |
| Female | |
| Graft vs Host Disease | |
| Humans | |
| Infant | |
| Infant, Newborn | |
| Male | |
| Multivariate Analysis | |
| Outcome Assessment, Health Care | |
| Proportional Hazards Models | |
| Recurrence | |
| Remission Induction | |
| Survival Analysis | |
| Survival Rate | |
| Time Factors | |
| Transplantation, Homologous |
Source PubMed
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41115238 | Immunotherapy in the up-front treatment of adult B-cell precursor acute lymphoblastic leukemia: when, how, who? | Blood Adv | 2026 | https://conductscience.org/library/papers/41115238 | PubMed |
| 39503988 | Therapeutic Drug Monitoring of Antimicrobial Drugs in Children with Cancer: A New Tool for Personalized Medicine. | Paediatr Drugs | 2025 | https://conductscience.org/library/papers/39503988 | PubMed |
| 37856089 | Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children. | Blood | 2023 | https://conductscience.org/library/papers/37856089 | PubMed |
| 36875838 | The emerging role of nutritional support in the supportive care of pediatric patients undergoing hematopoietic stem cell transplantation. | Front Nutr | 2023 | https://conductscience.org/library/papers/36875838 | PubMed |
| 36790458 | ERCC6L2-related disease: a novel entity of bone marrow failure disorder with high risk of clonal evolution. | Ann Hematol | 2023 | https://conductscience.org/library/papers/36790458 | PubMed |
| 35956160 | Antimicrobial Stewardship Interventions in Pediatric Oncology: A Systematic Review. | J Clin Med | 2022 | https://conductscience.org/library/papers/35956160 | PubMed |
| 35507103 | Hematopoietic stem cell transplantation for acute lymphoblastic leukemia: why do adolescents and young adults outcomes differ from those of children? A retrospective study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC). | J Cancer Res Clin Oncol | 2023 | https://conductscience.org/library/papers/35507103 | PubMed |
| 35071133 | Current Prophylaxis and Treatment Approaches for Acute Graft-Versus-Host Disease in Haematopoietic Stem Cell Transplantation for Children With Acute Lymphoblastic Leukaemia. | Front Pediatr | 2021 | https://conductscience.org/library/papers/35071133 | PubMed |
| 34501237 | The Role of Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Leukemia. | J Clin Med | 2021 | https://conductscience.org/library/papers/34501237 | PubMed |
| 33557125 | Fecal Microbiota Transplantation in Allogeneic Hematopoietic Stem Cell Transplantation Recipients: A Systematic Review. | J Pers Med | 2021 | https://conductscience.org/library/papers/33557125 | PubMed |
| 33530464 | Microbiome-Derived Metabolites in Allogeneic Hematopoietic Stem Cell Transplantation. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33530464 | PubMed |
| 32523362 | Cost-Effectiveness Analysis of Tisagenlecleucel in the Treatment of Relapsed or Refractory B-Cell Acute Lymphoblastic Leukaemia in Children and Young Adults in Spain. | Clinicoecon Outcomes Res | 2020 | https://conductscience.org/library/papers/32523362 | PubMed |
| 30302205 | Five-year direct costs of acute lymphoblastic leukemia pediatric patients undergoing allogeneic stem cell transplant. | Int J Hematol Oncol | 2016 | https://conductscience.org/library/papers/30302205 | PubMed |
| 28686179 | When Less Is Good, Is None Better? The Prognostic and Therapeutic Significance of Peri-Transplant Minimal Residual Disease Assessment in Pediatric Acute Lymphoblastic Leukemia. | J Clin Med | 2017 | https://conductscience.org/library/papers/28686179 | PubMed |
| 28438676 | Factors Associated with Long-Term Risk of Relapse after Unrelated Cord Blood Transplantation in Children with Acute Lymphoblastic Leukemia in Remission. | Biol Blood Marrow Transplant | 2017 | https://conductscience.org/library/papers/28438676 | PubMed |
| 26808568 | Improved outcome of children transplanted for high-risk leukemia by using a new strategy of cyclosporine-based GVHD prophylaxis. | Bone Marrow Transplant | 2016 | https://conductscience.org/library/papers/26808568 | PubMed |
| 26266406 | Role of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in Children. | Int J Mol Sci | 2015 | https://conductscience.org/library/papers/26266406 | PubMed |
| 25961775 | Risk factors and timing of relapse after allogeneic transplantation in pediatric ALL: for whom and when should interventions be tested? | Bone Marrow Transplant | 2015 | https://conductscience.org/library/papers/25961775 | PubMed |
| 25862561 | IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patients. | Blood | 2015 | https://conductscience.org/library/papers/25862561 | PubMed |
| 25387094 | Outcome of children with high-risk acute myeloid leukemia given autologous or allogeneic hematopoietic cell transplantation in the aieop AML-2002/01 study. | Bone Marrow Transplant | 2015 | https://conductscience.org/library/papers/25387094 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22010101
GET https://conductscience.org/api/papers/v1/22010101/cited_by?page=2